Search Results - "Ristow, K"

Refine Results
  1. 1

    Bowel perforation in intestinal lymphoma: incidence and clinical features by Vaidya, R., Habermann, T.M., Donohue, J.H., Ristow, K.M., Maurer, M.J., Macon, W.R., Colgan, J.P., Inwards, D.J., Ansell, S.M., Porrata, L.F., Micallef, I.N., Johnston, P.B., Markovic, S.N., Thompson, C.A., Nowakowski, G.S., Witzig, T.E.

    Published in Annals of oncology (01-09-2013)
    “…Perforation is a serious life-threatening complication of lymphomas involving the gastrointestinal (GI) tract. Although some perforations occur as the initial…”
    Get full text
    Journal Article
  2. 2

    Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin’s lymphoma by PORRATA, Luis F, RISTOW, Kay, THOMPSON, Carrie, MARKOVIC, Svetomir N, COLGAN, Joseph P, HABERMANN, Thomas M, WITZIG, Thomas E, INWARDS, David J, ANSELL, Stephen M, MICALLEF, Ivana N, JOHNSTON, Patrick B, NOWAKOWSKI, Grzegorz S

    Published in Haematologica (Roma) (01-02-2012)
    “…Lymphopenia and tumor-associated macrophages are negative prognostic factors for survival in classical Hodgkin's lymphoma. We, therefore, studied whether the…”
    Get full text
    Journal Article
  3. 3

    The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma by Wilcox, R A, Ristow, K, Habermann, T M, Inwards, D J, Micallef, I N M, Johnston, P B, Colgan, J P, Nowakowski, G S, Ansell, S M, Witzig, T E, Markovic, S N, Porrata, L

    Published in Leukemia (01-09-2011)
    “…Despite the use of modern immunochemotherapy regimens, almost 50% of patients with diffuse large-B-cell lymphoma will relapse. Current prognostic models,…”
    Get full text
    Journal Article
  4. 4
  5. 5

    The role of front-line anthracycline-containing chemotherapy regimens in peripheral T-cell lymphomas by Briski, R, Feldman, A L, Bailey, N G, Lim, M S, Ristow, K, Habermann, T M, Macon, W R, Inwards, D J, Colgan, J P, Nowakowski, G S, Kaminski, M S, Witzig, T E, Ansell, S M, Wilcox, R A

    Published in Blood cancer journal (New York) (30-05-2014)
    “…Peripheral T-cell lymphomas (PTCLs) are a heterogenous group of aggressive non-Hodgkin’s lymphomas that are incurable in the majority of patients with current…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Peripheral blood absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles predicts clinical outcomes in classical Hodgkin lymphoma by Porrata, L F, Ristow, K M, Habermann, T M, Macon, W R, Witzig, T E, Colgan, J P, Inwards, D J, Ansell, S M, Micallef, I N, Johnston, P B, Nowakowski, G, Thompson, C A, Markovic, S N

    Published in Blood cancer journal (New York) (01-04-2013)
    “…The peripheral blood absolute lymphocyte/monocyte count ratio at diagnosis (ALC/AMC-DX) predicts survival in classical Hodgkin lymphoma (cHL). However, a…”
    Get full text
    Journal Article
  9. 9

    Incidence of Constitutive and Inducible Clindamycin Resistance in Staphylococcus aureus and Coagulase-Negative Staphylococci in a Community and a Tertiary Care Hospital by SCHRECKENBERGER, Paul C, ILENDO, Elizabeth, RISTOW, Kathryn L

    Published in Journal of Clinical Microbiology (01-06-2004)
    “…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Differences between early and late posttransplant lymphoproliferative disorders in solid organ transplant patients: Are they two different diseases? by GHOBRIAL, Irene M, HABERTNANN, Thomas M, MACON, William R, RISTOW, Kay M, LARSON, Timothy S, WALKER, Randall C, ANSELL, Stephen M, GORES, Gregory J, STEGALL, Mark D, MCGREGOR, Christopher G

    Published in Transplantation (27-01-2005)
    “…The objective of the authors' study was to characterize the clinical and pathologic differences between patients who develop posttransplant lymphoproliferative…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Evaluation of RapiDEC Staph for identification of Staphylococcus aureus, Staphylococcus epidermidis, and Staphylococcus saprophyticus by JANDA, W. M, RISTOW, K, NOVAK, D

    Published in Journal of Clinical Microbiology (01-09-1994)
    “…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  14. 14
  15. 15

    PS1249 EXTRANODAL AND SPLEEN DISEASE DETECTED BY FDG‐PET/CT IS ASSOCIATED WITH EARLY CLINICAL FAILURE IN UNTREATED FOLLICULAR LYMPHOMA by St‐Pierre, F., Broski, S., Laplant, B., Ristow, K., Maurer, M., Macon, W., Habermann, T., Ansell, S., Thompson, C., Micallef, I., Nowakowski, G., Witzig, T.

    Published in HemaSphere (01-06-2019)
    “…Background: Predicting early clinical failure in patients with untreated follicular lymphoma (FL) is important but difficult. Lymphoma involvement of…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Absolute lymphocyte count at time of radioimmunotherapy predicted time to progression in patients with relapsed follicular lymphomas by Porrata, L. F., Ristow, K., Witzig, T. E., Wiseman, G. A., Tuinstra, N., Markovic, S. N.

    Published in Journal of clinical oncology (20-06-2007)
    “…Abstract only 18505 Background: Besides radiation, the immunologic mechanisms of action of 90 Y ibritumomab tiuxetan (Zevalin) radioimmunotherapy (RIT) have…”
    Get full text
    Journal Article
  18. 18

    Clinical outcome of patients with subcutaneous panniculitis-like T-cell lymphoma by Ghobrial, Irene M, Weenig, Roger H, Pittlekow, Mark R, Qu, Guangzhi, Kurtin, Paul J, Ristow, Kay, Ansell, Stephen M

    Published in Leukemia & lymphoma (01-05-2005)
    “…Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare form of cytotoxic T-cell lymphoma. The objective of this study was to characterize the…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Bleomycin Pulmonary Toxicity Has a Negative Impact on the Outcome of Patients With Hodgkin's Lymphoma by MARTIN, William G, RISTOW, Kay M, HABERMANN, Thomas M, COLGAN, Joseph P, WITZIG, Thomas E, ANSELL, Stephen M

    Published in Journal of clinical oncology (20-10-2005)
    “…Bleomycin pulmonary toxicity (BPT) has been well described in Hodgkin's lymphoma (HL) patients treated with bleomycin-containing chemotherapy regimens. The…”
    Get full text
    Journal Article